Patent · US Active

Chemical compounds

US7691867B2 · kind B2 · utility

0Cited by
3References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2004
Grant dateApr 6, 2010
Priority date
Expiry dateMar 28, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Quinazoline derivatives of formula (I); for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to process for their preparation, as well as pharmaceutical compositions containing them as active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.